Synlett 2011(14): 1997-2000  
DOI: 10.1055/s-0030-1261174
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

A Domino Microwave-Assisted Protocol for the Synthesis of 2,6-Disubstituted Pyrimidinones

Marco Radia,, Gianni Casalucea,, Maurizio Botta*a,b
a Dipartimento Farmaco Chimico Tecnologico, University of Siena, Via Alcide de Gasperi 2, 53100 Siena, Italy
b Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, BioLife Science Building, Suite 333, 1900 N 12th Street, Philadelphia, PA 19122, USA
Fax: +39(0577)234333; e-Mail: botta.maurizio@gmail.com;
Further Information

Publication History

Received 10 June 2011
Publication Date:
10 August 2011 (online)

Abstract

A practical microwave-assisted protocol for the synthesis of 2,6-disubstituted pyrimidinones has been developed. This approach is based on a domino Michael addition-cyclocondensation reaction between substituted thioureas/guanidines and acetylenecarboxylates. The application of such protocol for the synthesis of not easily accessible N-DABO derivatives as potential antiviral agents is also reported.

    References and Notes

  • 2a Radi M. Schenone S. Botta M. Org. Biomol. Chem.  2009,  7:  2841 
  • 2b Hill MD. Movassaghi M. Chem. Eur. J.  2008,  14:  6836 
  • 3 Boone LR. Curr. Opin. Invest. Drugs  2006,  7:  128 
  • 4 Barbaro G. Scozzafava A. Mastrolorenzo A. Supuran CT. Curr. Pharm. Des.  2005,  11:  1805 
  • 5 Botta M. Artico M. Massa S. Gambacorta A. Marongiu ME. Pani A. La Colla P. Eur. J. Med. Chem.  1992,  27:  251 
  • 6a Radi M. Maga G. Alongi M. Angeli L. Samuele A. Zanoli S. Bellucci L. Tafi A. Casaluce G. Giorgi G. Armand-Ugon M. Gonzalez E. Esté JA. Baltzinger M. Bec G. Dumas P. Ennifar E. Botta M. J. Med. Chem.  2009,  52:  840 
  • 6b Mugnaini C. Alongi M. Togninelli A. Gevariya H. Brizzi A. Manetti F. Bernardini C. Angeli L. Tafi A. Bellucci L. Corelli F. Massa S. Maga G. Samuele A. Facchini M. Clotet-Codina I. Armand-Ugón M. Esté JA. Botta M. J. Med. Chem.  2007,  50:  6580 
  • 7 Botta M, Corelli F, Petricci E, Radi M, Maga G, Esté JA, and Mai A. inventors; Int. Patent  WO2007043094. 
  • 8 Rotili D. Artico M. Sbardella G. Clotet-Codina I. Esté JA. Crespan E. Zanoli S. Hübscher U. Spadai S. Maga G. ChemMedChem  2007,  2:  445 
  • 9 Mai A. Artico M. Ragno R. Sbardella G. Massa S. Musiu C. Mura M. Marturana F. Cadeddu A. Maga G. La Colla P. Bioorg. Med. Chem.  2005,  13:  2065 
  • 10 Botta M. De Angelis F. Finizia G. Gambacorta A. Nicoletti R. Synth. Commun.  1985,  15:  27 
  • 11 Mai A. Artico M. Rotili D. Tarantino D. Clotet-Codina I. Armand-Ugn M. Ragno R. Simeoni S. Sbardella G. Nawrozkij MB. Samuele A. Maga G. Est JA. J. Med. Chem.  2007,  50:  5412 
  • 12a Radi M. Botta L. Casaluce G. Bernardini M. Botta M. J. Comb. Chem.  2010,  12:  200 
  • 12b Radi M. Bernardo V. Bechi B. Castagnolo D. Pagano M. Botta M. Tetrahedron Lett.  2009,  50:  6572 
  • 12c Radi M. Saletti S. Botta M. Tetrahedron Lett.  2008,  49:  4464 
  • 12d Castagnolo D. Dessì F. Radi M. Botta M. Tetrahedron: Asymm.  2007,  18:  1345 
  • 13 Karpov AS. Müller TJJ. Synthesis  2003,  2815 
  • 14 Karpov AS. Müller TJJ. Org. Lett.  2003,  5:  3451 
  • 15 Gupta KA. Saxena AK. Jain P. Synthesis  1981,  905 
  • 16 Piers E. Chong JM. Morton HE. Tetrahedron  1989,  45:  363 
  • 17 Bartoccini G. Master’s Thesis   University of Siena; Italy: 2010. 
  • 19 Corey EJ. Fuchs PL. Tetrahedron Lett.  1972,  36:  3769 
  • 20 Ohira S. Synth. Commun.  1989,  19:  561 
  • 21 Müller S. Liepold B. Roth GJ. Bestmann HJ. Synlett  1996,  521 
  • 22 Vasilevsky SF. Trofimov BA. Mal’kina AG. Brandsma L. Synth. Commun.  1994,  24:  85 
  • 24 Skulnick HI. Ludens JH. Wendling MG. Glenn EM. Rohloff NA. Smith RJ. Wierenga W. J. Med. Chem.  1986,  29:  1499 
1

These authors contributed equally to this work.

18

Typical Experimental Procedure: In a microwave sealed tube, S-methylisothiourea sulfate (1; 79 mg, 0.283 mmol), ethyl 4-(tetrahydro-2H-pyran-2-yloxy)but-2-ynoate (2; 50 mg, 0.236 mmol) and Na2CO3 (60 mg, 0.566 mmol) in DMF or t-BuOH (3 mL) were irradiated for 20 min in a self-tunable CEM microwave synthesizer at 120 ˚C and finally allowed to cool to r.t. When DMF was used as solvent, H2O was added and the aqueous layer was extracted with EtOAc (2 ×). The organic layers were collected, washed with brine, dried over Na2SO4 and concentrate under reduced pressure. When t-BuOH was used as solvent, the reaction mixture was directly evaporated to dryness to give a solid crude material. The residue was purified by flash chromatography (petroleum ether-EtOAc) to obtain 2-(methylthio)-6-[(tetrahydro-2H-pyran-2-yloxy)methyl]pyrimidin-4(3H)-one (3; 52-54%) as a white solid. ¹H NMR (400 MHz, CDCl3): δ = 12.68 (br s, 1 H), 6.34 (s, 1 H), 4.68 (s, 1 H), 4.52 (d, J = 16.0 Hz, 1 H), 4.32 (d, J = 16.0 Hz, 1 H), 3.77 (m, 1 H), 3.47 (m, 1 H), 2.48 (s, 3 H), 1.40-1.90 (m, 8 H). ¹³C NMR (100 MHz, CDCl3): δ = 166.33, 165.29, 161.36, 105.81, 98.12, 67.81, 61.91, 30.33, 25.36, 18.93, 13.19. MS (ESI): m/z = 257.3 [M + H]+.

23

Data not shown.